Pharmacotherapy of alpha-gamma-epsilon-alpha___ alpha___ kappa_coalition for the supply of alpha-gamma-epsilon-alpha___to alpha-gamma-epsilon-alpha-kappa__

摘要

The present invention relates to the use of a specific thromboxane prostaglandin receptor antagonist - (TP) for receiving drugs In patients with vascular endothelial disease, a precedent for cerebrovascular events is shown.Especially for patients with vascular and cardiovascular events, they showed a precedent for cerebral ischemic stroke (AIC) or P. Alpha ischemic sinus seizure (application).